Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 1
2007 2
2009 3
2010 2
2011 2
2012 7
2013 6
2014 5
2015 10
2016 8
2017 7
2018 11
2019 19
2020 22
2021 13
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

108 results
Results by year
Filters applied: . Clear all
Page 1
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B; ARASENS Trial Investigators. Smith MR, et al. Among authors: fu c. N Engl J Med. 2022 Mar 24;386(12):1132-1142. doi: 10.1056/NEJMoa2119115. Epub 2022 Feb 17. N Engl J Med. 2022. PMID: 35179323 Clinical Trial.
Detecting urine metabolites of bladder cancer by surface-enhanced Raman spectroscopy.
Hu D, Xu X, Zhao Z, Li C, Tian Y, Liu Q, Shao B, Chen S, Zhao Y, Li L, Bi H, Chen A, Fu C, Cui X, Zeng Y. Hu D, et al. Among authors: fu c. Spectrochim Acta A Mol Biomol Spectrosc. 2021 Feb 15;247:119108. doi: 10.1016/j.saa.2020.119108. Epub 2020 Oct 24. Spectrochim Acta A Mol Biomol Spectrosc. 2021. PMID: 33161263
108 results